Hoth Therapeutics, Inc. (HOTH) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.05M | -2.15M | -2.49M | -2.37M | -2.79M | -2.03M | -1.63M | -1.59M | -1.72M | -3.07M | -1.64M | -1.45M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -9.42% | -6.03% | -52.5% | -49.07% | -61.72% | 33.97% | 0.12% | -9.8% | 24.7% | -20.44% | 31.49% | 34.78% |
| Net Income | -2.69M | -2.69M | -4.11M | -2.2M | -3.48M | -2.38M | -2.13M | -1.71M | -2.04M | -1.7M | -2.09M | -1.87M |
| Depreciation & Amortization | 0 | 0 | 0 | -4.35K | 4.35K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 219.93K | 541 | 283.33K | 7.05K | 513.35K | 5.79K | 190.26K | 9.75K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 43.14K | 193.27K | 1.16M | 58.77K | 850.5K | 0 | 0 | 0 | 580 | -229.83K | -33.75K | 166.57K |
| Working Capital Changes | -401.21K | 344.54K | 454.36K | -227.78K | -386.97K | 354.44K | 214.16K | 111.39K | -197.1K | -1.15M | 293.49K | 247.01K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -14.41K | 447.91K | 655.78K | -443.13K | -16.39K | 23.61K | 128.47K | 40.24K | -39.3K | -1.24M | 207.18K | 378.16K |
| Cash from Investing | 147.2K | 0 | -300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 147.2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 701.48K | 550.14K | 1.63M | 66.1K | 7.07M | 1.06M | 0 | 3.68M | 0 | 0 | 2.41M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 701.48K | 550.14K | 2M | 66.1K | 7.07M | 1.06M | 0 | 3.68M | 0 | 0 | 2.41M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -376K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 495 | 0 |
| Net Change in Cash | -2.2M | -1.6M | -1.17M | -2.3M | 4.28M | -983.84K | -1.63M | 2.09M | -1.73M | -2.54M | 283.44K | -1.5M |
| Free Cash Flow | -3.05M | -2.15M | -2.49M | -2.37M | -2.79M | -2.03M | -1.63M | -1.59M | -1.72M | -3.07M | -1.64M | -1.45M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -9.42% | -6.03% | -52.5% | -49.07% | -61.72% | 33.97% | 0.12% | -9.8% | 24.7% | -20.44% | 31.49% | 36.25% |
| FCF per Share | -0.19 | -0.14 | -0.18 | -0.18 | -0.29 | -0.28 | -0.24 | -0.23 | -0.39 | -0.71 | -0.47 | -0.44 |
| FCF Conversion (FCF/Net Income) | 1.13x | 0.80x | 0.61x | 1.08x | 0.80x | 0.85x | 0.77x | 0.98x | 0.80x | 1.80x | 0.78x | 0.77x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |